Prospect Capital Corporation NT 061524
PBB
New York Stock Exchange- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Prospect Capital Corporation NT 061524 (PBB) represents unsecured senior notes issued by Prospect Capital Corporation, a leading publicly-traded business development company (BDC) founded in 2004 and headquartered in New York. Prospect Capital Corporation provides debt and equity financing to U.S. middle-market companies across diverse industries, including manufacturing, industrials, energy, business services, financial services, food, healthcare, media, and real estate; its core offerings encompass first-lien and second-lien senior secured loans, mezzanine debt, control-oriented private equity investments, real estate debt and equity positions such as mortgages and mezzanine loans, and investments in online lending platforms and collateralized loan obligations. The company targets private businesses for refinancing, leveraged buyouts, acquisitions, recapitalizations, growth capital, development financing, capital expenditures, and bridge loans, with a focus on sponsor-backed deals, direct lending to owner-operated firms, and fully developed Class B/C multi-family residential properties in secondary and tertiary U.S. markets. In recent developments, Prospect Capital Corporation completed the acquisition of QC Holdings, Inc., a consumer credit provider offering short-term loans and alternative financial services, in an all-cash transaction valued at approximately $115 million on June 30, 2025, with QC Holdings continuing operations from its Lenexa, Kansas headquarters under existing management. The company also closed $764 million in new investments during its fiscal year ended June 30, 2024, including $167 million in first-lien senior secured loans such as those to Verified Diagnostics for molecular testing and follow-on funding for portfolio company acquisitions and growth; earlier in fiscal 2025, it originated additional middle-market loans totaling significant volumes. These moves reflect ongoing portfolio expansion and strategic focus on senior secured lending amid diversified U.S. operations.